PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences

PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), today publishes its cash position as of June 30, 2023, and its financial calendar for the second half of 2023.